Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med...
by JumpCrisscross on Friday November 13, 2026 @09:26AM
(#50483977)
Eh, the counterpoint is individual scientists armed with AI to do research and probe targeted questions have succeeded in addressing rare diseases of personal interest.
What we just have no evidence for, to my knowledge, is someone with no medical background doing the same. Instead they wind up buying dodgy supplements and peptides.
What we just have no evidence for, to my knowledge, is someone with no medical background doing the same. Instead they wind up buying dodgy supplements and peptides.